0001179110-19-001057.txt : 20190129 0001179110-19-001057.hdr.sgml : 20190129 20190129174335 ACCESSION NUMBER: 0001179110-19-001057 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190125 FILED AS OF DATE: 20190129 DATE AS OF CHANGE: 20190129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kumar Ravindra CENTRAL INDEX KEY: 0001586835 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36065 FILM NUMBER: 19549710 MAIL ADDRESS: STREET 1: 128 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACCELERON PHARMA INC CENTRAL INDEX KEY: 0001280600 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 128 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-649-9200 MAIL ADDRESS: STREET 1: 128 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml FORM 4 - X0306 4 2019-01-25 0 0001280600 ACCELERON PHARMA INC XLRN 0001586835 Kumar Ravindra 128 SIDNEY STREET CAMBRIDGE MA 02139 0 1 0 0 SVP & Chief Scientific Officer Common Stock 2019-01-25 4 A 0 3850 0 A 93997 D Option to Purchase Common Stock 41.64 2019-01-25 4 A 0 21500 0 A 2029-01-25 Common Stock 21500 21500 D The shares of common stock underlying this stock option award vest in equal quarterly installments over the four years after January 1, 2019. /s/ John D. Quisel, as attorney-in-fact for Ravindra Kumar 2019-01-29